ncq 298 has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billings, J; Chumpradit, S; Kung, HF; Kung, MP; Mach, R | 1 |
| Bottoncetti, A; Meldolesi, U; Pecorale, A; Pupi, A; Raspanti, S; Sestini, S | 1 |
2 other study(ies) available for ncq 298 and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
| Article | Year |
|---|---|
Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
Topics: Animals; Benzamides; Dopamine Agents; Dopamine D2 Receptor Antagonists; Fluorine Radioisotopes; Iodine Radioisotopes; Macaca fascicularis; Male; Pyrrolidines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
First-pass cerebral extraction of benzamide-derivative radiotracers for SPECT.
Topics: Animals; Benzamides; Brain; Cerebrovascular Circulation; Dopamine Agonists; Iodine Radioisotopes; Male; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Salicylamides; Technetium; Tomography, Emission-Computed, Single-Photon | 1998 |